NeuroSense Therapeutics
milestones achieved upcoming potential catalysts | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
22 of 34
Similar slides by NeuroSense Therapeutics
See diffirences between slides (animation)
Investor Presentation
January 2024
milestones achieved and upcoming potential catalysts | NeuroSense Therapeutics
Investor Presentation
December 2023
milestones achieved and upcoming potential catalysts | NeuroSense Therapeutics
Related slides by other companies
Mink Therapeutics
IPO
October 2021
phase clinical trial focused in acute | Mink Therapeutics
Mink Therapeutics
IPO
October 2021
phase clinical trial focused in induced | Mink Therapeutics
NeuroBo Pharmaceuticals
Investor Presentation
March 2021
clinical trial design phase a | NeuroBo Pharmaceuticals
Kymera
Investor Presentation
August 2023
objectives a a | Kymera
Other recent decks by NeuroSense Therapeutics
See all presentations (3 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io